Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for Benign Prostatic Hyperplasia
NCT00827242Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of tadalafil in benign prostatic hyperplasia (BPH), sponsored by Eli Lilly and Company. Started Jan 2009; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00827242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827242.